Stock data
Haemonetics Corporation (HAE)
Haemonetics Corporation (HAE) reported revenue of US$1.33B and net income of US$97.31M for fiscal 2026. The figures below come from the company's SEC filings.
Annual results
Data as of 2026-03-28
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | US$1.33B | US$787.59M | US$156.73M | US$97.31M | — |
| 2025 | US$1.36B | US$748.96M | US$221.82M | US$167.68M | — |
| 2024 | US$1.31B | US$691.55M | US$164.88M | US$117.56M | — |
| 2023 | US$1.17B | US$615.10M | US$156.03M | US$115.40M | — |
| 2022 | US$993.20M | US$505.50M | US$80.75M | US$43.38M | — |
Quarterly results
Data as of 2026-06-27
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-27 | US$339.38M | US$33.01M | — |
| 2026-03-28 | US$346.35M | -US$20.15M | — |
| 2025-12-27 | US$338.97M | US$44.74M | — |
| 2025-09-27 | US$327.31M | US$38.68M | — |
| 2025-06-28 | US$321.39M | US$34.03M | — |
| 2025-03-29 | US$330.60M | US$57.98M | — |
| 2024-12-28 | US$348.54M | US$37.49M | — |
| 2024-09-28 | US$345.51M | US$33.83M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.